Novel bovine lentiviral vectors based on Jembrana disease virus

Journal of Gene Medicine

Volumn 2, Issue 3, 2000, Pages 176-185

  Metharom, Pat ^a   Takyar, Shervin ^a   Xia, Helen Huiqin ^a   Ellem, Kay A O ^a   Macmillan, John ^a   Shepherd, Ross W ^b   Wilcox, Graham E ^c   Wei, Ming Q ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

Author keywords

Bovine lentiviral vector; Gene expression; Gene transfer; Jembrana disease virus

Indexed keywords

ANIMALIA; BOS TAURUS; BOVINAE; HUMAN IMMUNODEFICIENCY VIRUS; JEMBRANA DISEASE VIRUS; LENTIVIRUS; PRIMATES; VESICULAR STOMATITIS VIRUS;

PRIMER DNA;

ANIMAL; ARTICLE; CATTLE; CELL LINE; DEFECTIVE VIRUS; GENE TRANSFER; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; HUMAN; LENTIVIRINAE; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CATTLE; CELL LINE; DEFECTIVE VIRUSES; DNA PRIMERS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; PLASMIDS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC;

EID: 0034180448     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-2254(200005/06)2:3<176::AID-JGM106>3.0.CO;2-Q     Document Type: Article

References (56)

1. Herman F. Clinical application of gene transfer. J Mol Med 1996; 74: 213-221.
2. Tait DL, Obermiller PS, Redlin-Frazier S, et al. Stability and toxicity of intraperitoneal LXSN-BRCA 1 retroviral vector following repeat administration. Clin Cancer Res 1997; 3(11): 1959-1968.
3. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
4. 1 human hematopoietic cells. Proc Natl Acad Sci U S A 1998; 95: 11939-11944.
5. Kahn ML, Lee SW, Dichek DA. Optimization of retroviral vector-mediated gene transfer into endothelial cells in vitro. Circ Res 1992; 71: 1508-1517.
6. Palmer TD, Rosman GJ, Osborne RAW, Miller AD. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci U S A 1991; 88(4): 1330-1334.
7. Bukrinsky MI, Sharova N, Dempsey MP, et al. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A 1992; 89: 6580-6889.
8. Bukrinsky MI, Haggerty S, Dempsey MP, et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365: 666-669.
9. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994; 68: 510-516.
10. Lever AML. HIV and other lentivirus-based vectors. Gene Ther 1996; 3: 470-471.
11. Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992; 11: 3053-3058.
12. Gallichan WS, Kafri T, Krahl T, et al. Lentivirus mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 1998; 9: 2717-2726.
13. + cells that mediated long-term engraftment of NOD/ SCID mice by HIV vectors. Science 1999; 283: 682-686.
14. Reiser J, Harmison G, Kluepfel-Stahl S, et al. Transduction of nondividing cells with pseudotyped defective high-titre HIV type 1 particles. Proc Natl Acad Sci U S A 1996; 93(4): 15266-15271.
15. Blömer U, Naldini L, Kafri T, et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997; 71(9): 6641-6649.
16. Naldini L, Blömer U, Gage FH, et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996; 93: 11382-11388.
17. Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
18. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U S A 1997; 94(19): 10319-10323.
19. Kafri T, Blömer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17: 314-317.
20. Amado RG, Chen ISY. Lentiviral vectors - the promise of gene therapy within reach? Science 1999; 285: 674-676.
21. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000; 7: 20-23.
22. Gasmi M, Glynn J, Jin MJ, et al. Minimum requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J Virol 1999; 73: 1828-1834.
23. Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873-9880.
24. Miyoshi H, Blömer U, Takahashi M, et al. Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150-8157.
25. Kalpana GV. Retroviral vectors for liver-directed gene therapy. Semin Liver Dis 1999; 19: 27-37.
26. Poeschla EM, Gilbert J, Li X, et al. Identification of a human immunodeficiency virus type 2 encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentiviral vectors. J Virol 1998; 72: 6527-6536.
27. Arya SK, Zamani M, Kundra P. Human immunodeficiency virus type lentiviral vectors for gene transfer: expression and potential for helper virus-free packaging. Hum Gene Ther 1998; 9: 1371-1380.
28. Federico M. Lentiviruses as gene delivery vectors. Curr Opin Biotechnol 1999; 10: 448-453.
29. Poeschla EM, Wong-Staal F, Looney DJ. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 1998; 4: 354-357.
30. Johnston JC, Gasmi M, Lim LE, et al. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol 1999; 73: 4991-5000.
31. Wang GS, Slepushkin V, Zabner J, et al. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest 1999 Dec; 104(11): R55-R62.
32. Olsen J. Gene transfer vectors derived from equine infectious anemia virus. Gene Ther 1998; 5: 1481-1487.
33. Mitrophanous KA, Yoon S, Rohll JB, et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther 1999; 6: 1808-1818.
34. Mselli-Lakhal L, Favier C, Da Silva Teixerira MF, et al. Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors. Arch Virol 1998; 143: 681-695.
35. Chadwick BJ, Coelen RJ, Sammels LM, et al. Genomic sequence analysis identifies Jembrana disease virus as a new bovine lentivirus. J Gen Virol 1995; 76: 189-192.
36. Chadwick BJ, Desport M, Brownlie J, et al. Detection of Jembrana disease virus in spleen, lymph nodes, bone marrow and other tissues by in situ hybridization of paraffin-embedded sections. J Gen Virol 1998; 79: 101-106.
37. Chen H, Wilcox GE, Kertayadnya G, Wood C. Characterization of the Jembrana Disease Virus tat gene and the cis- and trans-regulatory elements in its long terminal repeats. J Virol 1999; 73: 658-666.
38. Chadwick BJ, Coelen RJ, Wilcox GE, Kertayadnya G. Nucleotide sequence analysis of Jembrana disease virus: a bovine lentivirus associated with an acute disease syndrome. J Gen Virol 1995; 76: 1637-1650.
39. Rees S, Coote J, Stable J. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques 1996; 20(1): 102-110.
40. Wei MQ, Lejnieks DV, Ramesh N, et al. Sustained gene expression in transplanted skin fibroblasts in rats. Gene Ther 1999; 6: 840-844.
41. Ramesh N, Kim ST, Wei WQ, et al. High-titre bicistronic retroviral vectors employing foot-and-mouth diseases virus internal ribosome entry site. Nucleic Acids Res 1996; 24: 2697-2700.
42. Byrnes JJ. Structural and functional properties of DNA polymerase delta from rabbit bone marrow. Mol Cell Biochem 1984; 62(1): 13-24.
43. Huberman JA. New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase alpha. Cell 1981; 23(3): 647-648.
44. Wei MQ, Groth DM, Mendis AH, et al. Typing of methicillin-resistant Staphylococcus aureus with an M13 repeat. J Hosp Infect 1992; 25: 72-75.
45. Liu ML, Winther BL, Kay MA. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol 1997; 70: 2497-2502.
46. Miyake K, et al. Stable integration of HIV-based retroviral vectors into the chromosomes of nondividing cells. Hum Gene Ther 1998; 9: 467-475.
47. Wei P, Garber ME, Fang SM, et al. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998; 92: 451-462.
48. Ramabathan Y, Reza SM, Young TM, et al. Human and rodent transcription elongation factor P-TEFb: interaction with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate. J Virol 1999; 73: 5448-5458.
49. Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc Natl Acad Sci U S A 1999; 96(14): 7791-7796.
50. Chen HC, He J, Fong S, et al. Jembrana disease virus tat can regulate human immunodeficiency virus long terminal repeat-directed gene expression and can substitute for HIV tat in viral repication. J Virol 2000; 74: 2703-2713.
51. Richardson JH, Child LA, Lever AML. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5́ leader region. J Virol 1993; 67(7): 3997-4005.
52. Coffin JM. Retroviridae: the viruses and their replication. In Virology, Fields BN, Knipe DM, Howley PM (eds). Lippincott-Raven Publishers, USA. 1767-1847.
53. Keye JF, Richardson JH, Lever AML. Cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging. J Virol 1995; 69(10): 6588-6592.
54. Das AT, Klaver B, Klasens BIF. A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol 1997; 71(3): 2346-2356.
55. Bunn HF, Gu J, Huang LE, et al. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J Exp Biol 1998; 201 (Pt8): 1197-1201.
56. Fox JL. Researchers wary of fear-based ban on lentivirus gene therapy. Nat Biotechnol 1998; 16: 407